» Articles » PMID: 36795754

LncRNA Promotes Metastasis by Disrupting the WWP2-mediated Ubiquitination of Notch1

Abstract

Notch has been implicated in human cancers and is a putative therapeutic target. However, the regulation of Notch activation in the nucleus remains largely uncharacterized. Therefore, characterizing the detailed mechanisms governing Notch degradation will identify attractive strategies for treating Notch-activated cancers. Here, we report that the long noncoding RNA (lncRNA) drives breast cancer metastasis by stabilizing the Notch1 intracellular domain (NICD1). Moreover, we reveal WW domain containing E3 ubiquitin protein ligase 2 (WWP2) as an E3 ligase for NICD1 at K1821 and a suppressor of breast cancer metastasis. Mechanistically, impairs WWP2-NICD1 complex formation and in turn stabilizes NICD1, leading to Notch signaling activation and lung metastasis. loss sensitizes breast cancer cells to inhibition of Notch signaling and suppresses the growth of breast cancer patient-derived xenograft tumors, highlighting its therapeutic potential in breast cancer. Taken together, these results reveal the lncRNA as a putative regulator of Notch signaling and an oncogenic player driving breast cancer metastasis.

Citing Articles

Downregulation of lncRNA MNX1-AS1 promotes the ferroptosis and apoptosis of non-small cell lung cancer.

Chi X, Feng L, Wang L, Yu S, Wei M, Zhang Q Int J Med Sci. 2025; 22(5):1052-1063.

PMID: 40027180 PMC: 11866536. DOI: 10.7150/ijms.97790.


A Novel Prognostic Signature of Mitophagy-Related E3 Ubiquitin Ligases in Breast Cancer.

Bian K, Yang C, Zhang F, Huang L Int J Mol Sci. 2025; 26(4).

PMID: 40004017 PMC: 11855622. DOI: 10.3390/ijms26041551.


Long Non-Coding RNAs: Key Regulators of Tumor Epithelial/Mesenchymal Plasticity and Cancer Stemness.

Yuan Y, Tang Y, Fang Z, Wen J, Wicha M, Luo M Cells. 2025; 14(3).

PMID: 39937018 PMC: 11817775. DOI: 10.3390/cells14030227.


Long non-coding RNAs as key regulators of neurodegenerative protein aggregation.

Xu Q, Liu D, Zhu L, Su Y, Huang H Alzheimers Dement. 2025; 21(2):e14498.

PMID: 39936251 PMC: 11815248. DOI: 10.1002/alz.14498.


Comprehensive discovery and functional characterization of the noncanonical proteome.

Shi C, Liu F, Su X, Yang Z, Wang Y, Xie S Cell Res. 2025; 35(3):186-204.

PMID: 39794466 DOI: 10.1038/s41422-024-01059-3.


References
1.
Stoeck A, Lejnine S, Truong A, Pan L, Wang H, Zang C . Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov. 2014; 4(10):1154-67. PMC: 4184927. DOI: 10.1158/2159-8290.CD-13-0830. View

2.
Weng A, Ferrando A, Lee W, Morris 4th J, Silverman L, Sanchez-Irizarry C . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-71. DOI: 10.1126/science.1102160. View

3.
Reuter J, Mathews D . RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics. 2010; 11:129. PMC: 2984261. DOI: 10.1186/1471-2105-11-129. View

4.
Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C . The LINK-A lncRNA interacts with PtdIns(3,4,5)P to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol. 2017; 19(3):238-251. PMC: 5332298. DOI: 10.1038/ncb3473. View

5.
Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J . E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019; 573(7774):439-444. PMC: 7365572. DOI: 10.1038/s41586-019-1526-3. View